[The levels of antigens to plasminogen activators compared to their functional activity and inhibitor activity in patients with glomerulonephritis and amyloidosis].
Bumblite
I D
ID
Poliantseva
L R
LR
Mukhin
N A
NA
Andreenko
G V
GV
Podorol'skaia
L V
LV
Liaginskiĭ
A V
AV
Varlamova
N V
NV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000686:Amyloidosis / Q000276:immunology* / Q000378:metabolism; D000941:Antigens / Q000032:analysis*; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007674:Kidney Diseases / Q000276:immunology* / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D009404:Nephrotic Syndrome / Q000276:immunology / Q000378:metabolism; D010960:Plasminogen Activators / Q000032:analysis* / Q000276:immunology*; D015849:Plasminogen Inactivators / Q000032:analysis*; D011379:Prognosis; D011507:Proteinuria / Q000276:immunology / Q000378:metabolism
D000941:Antigens; D015849:Plasminogen Inactivators; D010960:Plasminogen Activators
Urovni antigenov aktivatorov plazminogena v sopostavlenii s ikh funktsional'noĭ aktivnost'iu i aktivnost'iu ingibitorov u bol'nykh glomerulonefritom i amiloidozom.